Baseline demographic and clinical characteristics of 117 critically ill patients with COVID-19 admitted to ICUs in Metro Vancouver, British Columbia
Characteristic | No. (%) of patients* |
---|---|
Demographic characteristic | |
Age, yr, median (IQR) | 69 (60–75) |
Sex, female | 38 (32.5) |
BMI, median (IQR)† | 28 (24–33) |
Time from symptom onset to ICU admission, d, mean (± SD) | 8.0 (± 4.5) |
APACHE II score, median (IQR)‡ | 18 (10–28) |
SOFA score at admission, median (IQR)§ | 6 (2–11) |
Enrolment site | |
Quaternary or tertiary A | 39 (33.3) |
Quaternary or tertiary B | 29 (24.8) |
Quaternary or tertiary C | 21 (17.9) |
Quaternary or tertiary D | 9 (7.7) |
Community A | 13 (11.1) |
Community B | 6 (5.1) |
Comorbidity | |
Hypertension | 54 (46.2) |
Dyslipidemia | 43 (36.8) |
Diabetes mellitus | 36 (30.8) |
None | 31 (26.5) |
Cardiovascular disease | 20 (17.1) |
Current or former tobacco smoker | 16 (13.7) |
Chronic kidney disease | 15 (12.8) |
Asthma | 14 (12.0) |
Chronic obstructive pulmonary disease | 8 (6.8) |
Active malignancy | 7 (6.0) |
Congestive heart failure | 4 (3.4) |
Hemorrhagic or ischemic stroke | 4 (3.4) |
Chronic liver disease | 2 (1.7) |
Note: APACHE = Acute Physiology and Chronic Health Evaluation, BMI = body mass index, COVID-19 = coronavirus disease 2019, ICU = intensive care unit, IQR = interquartile range, SD = standard deviation, SOFA = Sequential Organ Failure Assessment.
↵* Unless stated otherwise.
↵† BMI was recorded only for the 74 patients who underwent mechanical ventilation. Of these, 55 (74.3%) had data available.
↵‡ The APACHE II score is a measure of illness acuity with possible scores ranging from 0 to 71. Higher scores indicate more severe illness and are associated with greater mortality. APACHE II scores were available for 95 (81.2%) patients.
↵§ The SOFA score is a measure of illness acuity with possible scores ranging from 0 to 24. Higher scores indicate more severe illness and are associated with greater mortality. SOFA scores on day 1 of ICU admission were available for 115 (98.3%) patients.